Stay updated on Miransertib in Overgrowth Spectrum Clinical Trial

Sign up to get notified when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Miransertib in Overgrowth Spectrum Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, indicating an administrative update to the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:20:52.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1 and no longer shows Revision: v3.4.0, a minor metadata update that does not affect study details or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T22:38:12.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now includes a Show glossary option. The labels for QC criteria submission and No FEAR Act data have been updated, and the revision identifier was raised to v3.4.0 from v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T21:27:48.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The update is limited to a minor revision tag (v3.3.4 added; v3.3.3 removed) and does not modify study content, eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:55:31.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added study site locations: Georgia, Illinois, Massachusetts, Ohio, Texas, Washington, New South Wales, Roma, and Barcelona (revision v3.3.3). Removed corresponding location entries for Georgia, Illinois, Massachusetts, Ohio, Texas, Washington, New South Wales, Roma, and Barcelona (revision v3.3.2).
    Difference
    0.9%
    Check dated 2025-12-23T23:01:42.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    These additions and deletions describe how PubMed publications are automatically populated in the study record and report a revision version (Revision: v3.3.2). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:24:04.000Z thumbnail image

Stay in the know with updates to Miransertib in Overgrowth Spectrum Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.